Skip to main content

Prokidney Corp.

PROK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850270

In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Prokidney Corp. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of PROK: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders5667+11
Shares39.8M40.5M+686.9K (+1.7%)
Value$445.6M$185.4M−$260.2M (−58.4%)

New holders (17)

Institutions that held Prokidney Corp. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PROK in Q3 2023
InstitutionSharesValue% of portfolio
Millennium Management LLC213,746$979.0K0.00%
XTX Topco Ltd61,911$283.6K0.05%
Balyasny Asset Management LLC56,258$257.7K0.00%
Alliancebernstein L.P.48,040$220.0K0.00%
Jump Financial, LLC47,100$215.7K0.01%
Cubist Systematic Strategies, LLC38,903$178.2K0.00%
Tudor Investment Corp Et Al30,727$140.7K0.00%
D. E. Shaw & Co., Inc.27,616$126.5K0.00%
Trexquant Investment LP25,298$115.9K0.00%
Franklin Resources Inc20,186$92.5K0.00%
SG Americas Securities, LLC17,080$78.0K0.00%
Point72 Middle East FZE16,988$77.8K0.00%
Arrowstreet Capital, Limited Partnership15,202$70.0K0.00%
Envestnet Asset Management Inc13,340$61.1K0.00%
Federated Hermes, Inc.1,022$4.81K0.00%
Allspring Global Investments Holdings, LLC71$3250.00%
Simplex Trading, LLC119$00.00%

Sold out (6)

Institutions that held Prokidney Corp. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of PROK in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Susquehanna International Group, LLP57,123$639.2K
Price T Rowe Associates Inc12,501$140.0K
Salem Investment Counselors Inc3,000$33.6K
Citadel Advisors LLC900$10.1K
Nisa Investment Advisors, LLC43$481
Advisor Group Holdings, Inc.1$11